HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirak Der-Torossian Selected Research

sitravatinib

1/2022A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy.
10/2021Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirak Der-Torossian Research Topics

Disease

7Neoplasms (Cancer)
03/2022 - 12/2012
4Cachexia
07/2015 - 12/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Renal Cell Carcinoma (Grawitz Tumor)
01/2022
1Diarrhea
01/2022
1Fatigue
01/2022
1Nausea
01/2022
1Carcinoma (Carcinomatosis)
10/2021
1Hypertension (High Blood Pressure)
10/2021
1Hypoxia (Hypoxemia)
10/2021
1Thrombocytopenia (Thrombopenia)
10/2021
1Squamous Cell Carcinoma of Head and Neck
10/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
07/2015
1Atrophy
06/2013
1Muscle Weakness
04/2013

Drug/Important Bio-Agent (IBA)

2Docetaxel (Taxotere)FDA Link
03/2022 - 01/2022
2glesatinibIBA
03/2022 - 01/2022
2Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2022 - 01/2022
2NivolumabIBA
01/2022 - 10/2021
2sitravatinibIBA
01/2022 - 10/2021
2Biomarkers (Surrogate Marker)IBA
10/2021 - 04/2015
1B7-H1 AntigenIBA
01/2022
1adagrasibIBA
01/2022
1PlatinumIBA
01/2022
1Cell-Free Nucleic AcidsIBA
10/2021
1RNA (Ribonucleic Acid)IBA
10/2021
1Biological ProductsIBA
10/2021
1Circulating Tumor DNAIBA
10/2021
1NF-kappa B (NF-kB)IBA
06/2013
1Phosphotransferases (Kinase)IBA
06/2013
1Transcription Factors (Transcription Factor)IBA
06/2013
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
04/2013
1Myosins (Myosin)IBA
04/2013
1Proteins (Proteins, Gene)FDA Link
04/2013

Therapy/Procedure

3Therapeutics
01/2022 - 06/2013
1Drug Therapy (Chemotherapy)
01/2022
1Drug Tapering
10/2021
1Combined Modality Therapy
07/2015
1Aftercare (After-Treatment)
04/2015
1Caloric Restriction
12/2012